Emily Prince

2.3k total citations
4 papers, 77 citations indexed

About

Emily Prince is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Emily Prince has authored 4 papers receiving a total of 77 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Emily Prince's work include Cancer Immunotherapy and Biomarkers (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Cancer Genomics and Diagnostics (2 papers). Emily Prince is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Cancer Genomics and Diagnostics (2 papers). Emily Prince collaborates with scholars based in United States and China. Emily Prince's co-authors include Dimple Pandya, Jenine K. Sanzari, Robin Edwards, James Pratt, James Novotny, Jianjun Chen, Yalin Kang, Yueh‐Chiang Hu, Jiacheng Hu and Xiuxin Zhang and has published in prestigious journals such as Nature Communications, Cancer Research and Journal of Clinical Pathology.

In The Last Decade

Emily Prince

4 papers receiving 77 citations

Peers

Emily Prince
Suxia Luo China
Yaelle Tuvy United States
N. Girard France
Raheel Nathani United States
Foysal Daian United States
J.J. Lee United States
Jaseela Chiramel United Kingdom
Emily Prince
Citations per year, relative to Emily Prince Emily Prince (= 1×) peers Natalia Fadeeva

Countries citing papers authored by Emily Prince

Since Specialization
Citations

This map shows the geographic impact of Emily Prince's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Prince with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Prince more than expected).

Fields of papers citing papers by Emily Prince

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Prince. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Prince. The network helps show where Emily Prince may publish in the future.

Co-authorship network of co-authors of Emily Prince

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Prince. A scholar is included among the top collaborators of Emily Prince based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Prince. Emily Prince is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
Huang, Feng, Xiuxin Zhang, Jingwen Li, et al.. (2025). m6A/IGF2BP3-driven serine biosynthesis fuels AML stemness and metabolic vulnerability. Nature Communications. 16(1). 4214–4214. 4 indexed citations
2.
Prince, Emily, et al.. (2021). Analytical Concordance of PD-L1 Assays Utilizing Antibodies From FDA-Approved Diagnostics in Advanced Cancers: A Systematic Literature Review. JCO Precision Oncology. 5(5). 953–973. 39 indexed citations
3.
Mitra, Shreya, et al.. (2021). Abstract PS4-18: Real-world PD-L1 test utilization and analytical concordance of the PD-L1 IHC 28-8 and 22C3 assays in patients with breast cancer. Cancer Research. 81(4_Supplement). PS4–18. 1 indexed citations
4.
Prince, Emily, et al.. (2020). Analysis of real-world PD-L1 IHC 28-8 and 22C3 pharmDx assay utilisation, turnaround times and analytical concordance across multiple tumour types. Journal of Clinical Pathology. 73(10). 656–664. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026